Introduction and Epidemiology

  • Shahriar IslamEmail author
  • Angela M. Riddell
Part of the Clinicians’ Guides to Radionuclide Hybrid Imaging book series (CGRHI)


Oesophageal cancer is the third most common gastrointestinal malignancy worldwide. Over the last 40 years, the UK has seen a rise in prevalence and it is now the 13th most common cancer in adults [1]. It has an incidence of 8,300 new cases each year demonstrating a 2:1 preference for males to females. It is reported that 80 % of new cases are diagnosed in patients over 60 years of age [1]. The distribution of tumour subtype varies according to ethnicity with adenocarcinoma favouring Caucasians and squamous cell carcinomas favouring Asian, South American and African populations [2]. Despite advances in multimodality treatment, oesophageal cancer is still devastatingly aggressive with over 65 % of new cases incurable at time of presentation. The disease maintains a 5-year survival of just 15–20 % [3].


Gastric Cancer Oesophageal Cancer Gastric Cardia Oesophageal Adenocarcinoma Main Present Symptom 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
  2. 2.
    Farin K, Wong-Ho C, Christian A, Sanford D. Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 2009;38(1):27–vii.CrossRefGoogle Scholar
  3. 3.
    Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381:400–12.CrossRefPubMedGoogle Scholar
  4. 4.
    Allum WH, et al. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011;60(11):1449–72.CrossRefPubMedGoogle Scholar
  5. 5.
    Cheng KK, Sharp L, McKinney PA, et al. A case control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer. 2000;83:127e32.Google Scholar
  6. 6.
    Lindblad M, Rodriguez LA, Lagergren J. Body mass, tobacco and alcohol and risk of oesophageal, gastric cardia and gastric non-cardia adenocarcinoma among men and women in a nested case control study. Cancer Causes Control. 2005;16:285e94.CrossRefGoogle Scholar
  7. 7.
    Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: a cohort study. BMJ. 2007;335:1134.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Zhang HZ, Jin GF, Shen HB. Epidemiologic differences in esophageal cancer between Asian and Western populations. Chin J Cancer. 2012;31(6):281–6. doi: 10.5732/cjc.011.10390.PMC3777490.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Koshy M, Esiashvilli N, et al. Multiple management modalities in esophageal cancer: epidemiology, presentation and progression, work-up and surgical approaches. Oncologist. 2004;9(2):137–46.CrossRefPubMedGoogle Scholar
  10. 10.
    Yalamarthi S, Witherspoon P, McCole D, et al. Missed diagnoses in patients with upper gastrointestinal cancers. Endoscopy. 2004;36:874e9.CrossRefGoogle Scholar
  11. 11.
    Fitzgerald RC, Saeed IT, Khoo D, et al. Rigorous surveillance protocol increases detection of curable cancers associated with Barrett’s esophagus. Dig Dis Sci. 2001;46:1892e8.CrossRefGoogle Scholar
  12. 12.
    Bramble MG, Suvakovic Z, Hungin AP. Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy. Gut. 2000;46:464e7.CrossRefGoogle Scholar
  13. 13.
    Meister T, Heinzow HS, et al. Miniprobe endoscopic ultrasound accurately stages esophageal cancer and guides therapeutic decisions in the era of neoadjuvant therapy: results of a multicenter cohort analysis. Surg Endosc. 2013;27(8):2813–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Catalano MF, Sivak Jr MV, Rice T, et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc. 1994;40:442e6.Google Scholar
  15. 15.
    Vazquez-Sequeiros E, Norton ID, Clain JE, et al. Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc. 2001;53:751e7.13. Catalano MF, Sivak MV Jr, Rice T, et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc. 1994;40:442e6.Google Scholar
  16. 16.
    Bhandari S, Shim CS, Kim JH, et al. Usefulness of three-dimensional, multidetector row CT (virtual gastroscopy and multiplanar reconstruction) in the evaluation of gastric cancer: a comparison with conventional endoscopy, EUS, and histopathology. Gastrointest Endosc. 2004;59:619e26.CrossRefGoogle Scholar
  17. 17.
    Fukuya T, Honda H, Kaneko K, et al. Efficacy of helical CT in T-staging of gastric cancer. J Comput Assist Tomogr. 1997;21:73e81.CrossRefGoogle Scholar
  18. 18.
    Yajima K, et al. Clinical and diagnostic significance of preoperative computed tomography findings of ascites in patients with advanced gastric cancer. Am J Surg. 2006;192(2):185–90.CrossRefPubMedGoogle Scholar
  19. 19.
    Purandare NC, et al. Incremental value of 18F-FDG PET/CT in therapeutic decision-making of potentially curable esophageal adenocarcinoma. Nucl Med Commun. 2014;35(8):864–9.PubMedGoogle Scholar
  20. 20.
    Bruzzi JF, et al. PET/CT of esophageal cancer: its role in clinical management. Radiographics. 2007;27(6):1635–52.CrossRefPubMedGoogle Scholar
  21. 21.
    Edge S, et al. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 129–35.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of RadiologyThe Royal Marsden NHS TrustLondonUK
  2. 2.Department of Radiology/Biomedical Research CentreThe Royal Marsden NHS TrustLondonUK

Personalised recommendations